Abstract
Rare mutations in the VHL gene may lead to polycythemia in children. Ruxolitinib resulted in clinical improvement in three people with this disorder.
Cite
CITATION STYLE
APA
Zhou, A. W., Knoche, E. M., Engle, E. K., Ban-Hoefen, M., Kaiwar, C., & Oh, S. T. (2016). Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia. New England Journal of Medicine, 375(5), 494–496. https://doi.org/10.1056/nejmc1600337
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free